Polycystic Ovarian Syndrom. Endocrine, nutritional and metabolic diseases
Conditions
Interventions
Intervention 1: The first intervention group: 50 patients with polycystic ovary syndrome who were given metformin tablets 500 mg every 8 hours from Dineh Iran for three months. Intervention 2: Interve
Sponsors
Zahedan University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Women with polycystic ovarian syndrom based on the diagnostic criteria of rotterdam including ultrasound examination and symptoms of hyperandrogenism and menstural disorders and ruling out other endocrine disorderssuch as hyperprolactinemia,increase in the thickness of the outer layer of the ovary,cushing syndrom,acromegaly,androgen producing tumors and CAH
Exclusion criteria
Exclusion criteria: Cardiovascular disease Hepatic disease Renal disease Thyroid disease Sever glucose intolerance User of vitamine and mineral supplementary User of weight reducer drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lipid profile level. Timepoint: First and three months after the study. Method of measurement: with laboratory sampling in mg/dL.;Hormone profile levels such as testosterone and luteinizing hormone and Follicle-stimulating Hormone. Timepoint: First and three months after the study. Method of measurement: with laboratory sampling in IU/l.;Fasting blood sugar and insulin levels and HOMA-IR. Timepoint: First and three months after the study. Method of measurement: with laboratory sampling in mg/dL.;Average anthropometric indices such as waist circumference and hip circumference and body mass index. Timepoint: First and three months after the study. Method of measurement: By measuring weight in kilograms and height in centimeters. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Feghhi
Zahedan University of Medical Sciences
Outcome results
None listed